VCM
TYRA icon

Versant Capital Management’s Tyra Biosciences TYRA Stock Holding History

Versant Capital Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.2K Hold
819
– – ﹤0.01% 1791
2026
Q1 		$31.4K Hold
819
– – ﹤0.01% 1540
2025
Q4 		$21.5K Hold
819
– – ﹤0.01% 1593
2025
Q3 		$11.5K Hold
819
– – ﹤0.01% 1874
2025
Q2 		$7.84K Buy
+819
New +$7.78K ﹤0.01% 1994

Other funds holding TYRA

APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
AI
Auour Investments Woburn, Massachusetts $349M AUM 13.68% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Versant Capital Management's TYRA Position: Q2 2026 in Review

Versant Capital Management held its Tyra Biosciences (TYRA) position steady in Q2 2026 at 819 shares worth $26.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1791.

Versant Capital Management first reported a position in TYRA in Q2 2025 and has held it in 5 quarters since. The position peaked at $31.4K in Q1 2026. 16 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Versant Capital Management held 819 shares of Tyra Biosciences worth $26.2K as of Q2 2026.
  • Versant Capital Management left its Tyra Biosciences share count unchanged in Q2 2026.
  • Tyra Biosciences made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1791 holding.
  • Versant Capital Management first reported a position in Tyra Biosciences in Q2 2025 and has held it in 5 quarters since.
  • Versant Capital Management's Tyra Biosciences position peaked at $31.4K in Q1 2026.
  • 16 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.